Caxton Associates (UK)’s Procter & Gamble PG Stock Holding History

Caxton Associates (UK)’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,217	Closed	-$318K	–	954
2025 Q4	$318K	Buy	+2,217	New	+$327K	0.01%	605

Other funds holding PG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caxton Associates (UK)'s PG Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Procter & Gamble (PG) in Q1 2026, closing a stake of 2,217 shares — an estimated $318K sold.

Caxton Associates (UK) first reported a position in PG in Q4 2025 and held it in 1 quarter. The position peaked at $318K in Q4 2025. 3,986 funds tracked by Wall St. Rank hold PG as of Q1 2026.

Caxton Associates (UK) reported no remaining Procter & Gamble position as of Q1 2026 after selling out during the quarter.
Caxton Associates (UK) sold 2,217 Procter & Gamble shares in Q1 2026, an estimated $318K.
Caxton Associates (UK) first reported a position in Procter & Gamble in Q4 2025 and held it in 1 quarter.
Caxton Associates (UK)'s Procter & Gamble position peaked at $318K in Q4 2025.
3,986 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.